Home
About Us
Team
Investment Focus
Laboratory Products
Laboratory Services
Contract Manufacturing
Pharma Services
Specialty Pharma
Portfolio
News
Contact
News
May 12, 2020
May 12, 2020
Key Biologics and Astarte Biologics Rebrand as Cellero and Announce Completion of Phase One of $50 Million Multi-Year Expansion Plan
April 21, 2020
April 21, 2020
Tjoapack Receives Investment from Ampersand Capital Partners
March 31, 2020
March 31, 2020
Ampersand Closes Oversubscribed Fund at $690 Million Hard Cap
March 4, 2020
March 4, 2020
Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts
February 26, 2020
February 26, 2020
Adaptas Solutions to Acquire Applied Kilovolts and Analytical Instrumentation Business from L3Harris Technologies
January 28, 2020
January 28, 2020
Arranta Bio announces key leadership additions of Chief Operations Officer and SVP of Business Development as it commits to a $100M investment in building end-to-end microbiome capacity
January 17, 2020
January 17, 2020
Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services
January 13, 2020
January 13, 2020
Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners
December 16, 2019
December 16, 2019
Ampersand Capital Partners Acquires Peptides International And Merges Company With New England Peptide
December 4, 2019
December 4, 2019
Canopy Biosciences Acquires Core Diagnostics
1
2
3
...
11
Next page
